The Medical Microbiology Fellowship at Beth Israel Deaconess Medical Center was accredited by the ACGME in 2008. The program is one year in length and qualifies fellows to sit for the Medical Microbiology Board Examination, a subspecialty board of the American Board of Pathology. A pre-requisite for fellowship training is successful completion of either a pathology residency training program (in AP and/or CP) or an infectious disease fellowship. The goal of the program is to train fellows to assume leadership roles in academic, tertiary care, or public health microbiology laboratories. Philosophically we believe that this education is best accomplished through hands-on instruction in microbiological methods, direct participation in the consultative and administrative activities of the microbiology laboratory, and participation in activities of the infectious disease, pharmacy, and infection control/hospital epidemiology departments. The organization of the program reflects these goals. Fellows have rotations at Children's Hospital Boston and the Massachusetts State Laboratory to ensure sufficient exposure to pediatric and public health microbiology, respectively. Applications may be obtained from Joan Allin, BIDMC Residency and Fellowships Training Coordinator (firstname.lastname@example.org).
We also received approval for the only American Academy of Microbiology-accredited Medical Microbiology Fellowship Program in New England. The goals and organization are similar to our ACGME-accredited program. At the end of their training, fellows will qualify to sit for the CPEP-Board Examination in Medical and Public Health Microbiology. There are currently no available positions.
James E. Kirby, MD, Medical Director, Clinical Microbiology, Beth Israel Deaconess Medical Center
Associate Program Directors
Qinfang Qian, MD, PhD, Assistant Director, Clinical Microbiology, Beth Israel Deaconess Medical Center
Alex McAdam, MD, PhD, Chief and Medical Director, Division of Infectious Disease Diagnostics, Children's Hospital Boston
Michael Pentella, PhD, Director, Division of Microbiology, Massaschusetts State Laboratory Instutitue, Massachusetts Department of Public Health